| | |
1 MHz, Tmax
|
10 MHz, Tmax
|
|---|
|
Variables
|
Number
|
Median
|
P-value
|
Median
|
P-value
|
|---|
|
Gender (Male: Female)
|
41: 8
|
1320: 1260
|
0.569
|
1620: 1500
|
0.705
|
|
Smoking history (+: -)
|
42: 7
|
1320: 1320
|
0.841
|
1560: 1800
|
0.852
|
|
Hypertension (+: -)
|
32: 17
|
1290: 1440
|
0.338
|
1500: 1740
|
0.152
|
|
Dyslipidemia (+: -)
|
25: 24
|
1260: 1440
|
0.173
|
1500: 1650
|
0.652
|
|
Coronary artery disease (+: -)
|
5: 44
|
1320: 1320
|
0.987
|
1740: 1560
|
0.741
|
|
Cerebrovascular disease (+: -)
|
9: 40
|
1200: 1410
|
0.1473
|
1500: 1650
|
0.224
|
|
Chronic kidney disease (+: -)
|
11: 38
|
1080: 1380
|
0.167
|
1260: 1710
|
0.052
|
|
Diabetes mellitus (+: -)
|
22: 27
|
1170: 1500
|
0.010
|
1470: 1800
|
0.011
|
|
Ca-blocker (+: -)
|
24: 25
|
1320: 1320
|
0.711
|
1500: 1680
|
0.331
|
|
β-blocker (+: -)
|
6: 43
|
1500: 1320
|
0.492
|
1680: 1560
|
0.783
|
|
ACE-I (+: -)
|
2: 47
|
1440: 1320
|
0.667
|
1620: 1560
|
0.859
|
|
ARB (+: -)
|
20: 29
|
1290: 1320
|
0.714
|
1500: 1680
|
0.154
|
|
Statin (+: -)
|
22: 27
|
1260: 1440
|
0.487
|
1620: 1560
|
0.840
|
|
Antiplatelet (+: -)
|
44: 5
|
1350: 1320
|
0.620
|
1560: 1620
|
0.408
|
-
IQR interquartile range; ACE-I angiotensin converting enzyme – inhibitor; ARB angiotensin II receptor blocker
